Allurion Technologies Inc
ALUR
查看详细走势图
1.100USD
+0.030+2.80%
收盘 02/06, 16:00（美东）报价延迟15分钟
8.54M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+2.80%
5天
-18.52%
1月
-34.52%
6月
-60.14%
今年开始到现在
-10.57%
1年
-81.79%
查看详细走势图
TradingKey Allurion Technologies Inc股票评分
单位: USD 更新时间: 2026-02-06操作建议
Allurion Technologies Inc当前公司基本面数据相对健康，最新ESG披露属于行业领先水平。增长潜力稳定。当前估值合理，在软件与IT服务行业排名188/482位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价5.25。中期看，股价处于下降通道。近一个月，市场表现非常差，基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间，可以做区间波段操作。
Allurion Technologies Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看空
Allurion Technologies Inc亮点
亮点风险
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
业绩增长期
公司处于发展阶段，最新年度总收入32.11M美元
估值高估
公司最新PE估值-0.00，处于3年历史高位
机构加仓
最新机构持股6.53M股，环比增加33.90%
先锋集团持仓
明星投资者先锋集团持仓，最新持仓市值88.65K
分析师目标
根据
2
位分析师
买入
评级
5.250
目标均价
+344.92%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Allurion Technologies Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Allurion Technologies Inc简介
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
公司代码ALUR
公司Allurion Technologies Inc
CEOGaur (Shantanu)
网址https://www.allurion.com/en
相关品种
